Mesalazine granted US FDA approval for ulcerative colitis.

Source: Inpharma, Volume 1, Number 1663, 2008-11-08 , pp. 23-23(1)

Keywords: Controlled-release-drugs; Development-status; Mesalazine, therapeutic use; Product-approvals; Ulcerative-colitis, treatment

Document Type: Short communication

Links for this article

http://www.ingentaconnect.com/adis/inp/2008/00000001/00001663/art00069
http://openurl.ingenta.com/content?genre=article&issn=1173-8324&volume=1&issue=1663&spage=23&epage=23